• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED - Corporate Spotlight

6.86% ! 47.5¢
Market Cap $285.0M  !
Healthcare Biotechnology
Add to My Watchlist

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
47.5¢ 		Change
-0.035(6.86%) 		Mkt cap ! $285.0M
Open High Low Value Volume
51.0¢ 51.0¢ 47.5¢ $1.682M 3.440M

Buyers (Bids)

No. Vol. Price($)
6 73129 47.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 91753 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
Last
48.0¢ 		  Change
-0.035 ( 4.29 %)
Open High Low Volume
51.0¢ 51.0¢ 47.5¢ 1488932
Last updated 15.58pm 30/07/2025 ?
DXB (ASX) Chart

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
Ionic Rare Earths falls -7% as momentum slips on vague production update Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.